Medical News

Medical Breakthrough: FDA Grants Accelerated Approval to CRISPR-Based Alzheimer's Therapy

The US Food and Drug Administration has granted accelerated approval to 'Synapta,' the first gene-editing therapy designed to halt and potentially reverse the progression of early-stage Alzheimer's.